Anticancer Analysis of CD44 Targeted Cyclosporine Loaded Thiolated Chitosan Nanoformulations for Sustained Release in Triple-Negative Breast Cancer.

Abduh MS

Open source

DOI
10.2147/ijn.s424932
Published
2023
Container
International journal of nanomedicine
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/ijn.s424932,
  title = {Anticancer Analysis of CD44 Targeted Cyclosporine Loaded Thiolated Chitosan Nanoformulations for Sustained Release in Triple-Negative Breast Cancer.},
  author = {Abduh MS},
  year = {2023},
  journal = {International journal of nanomedicine},
  doi = {10.2147/ijn.s424932},
  url = {https://doi.org/10.2147/ijn.s424932}
}

RIS

TY  - JOUR
TI  - Anticancer Analysis of CD44 Targeted Cyclosporine Loaded Thiolated Chitosan Nanoformulations for Sustained Release in Triple-Negative Breast Cancer.
AU  - Abduh MS
PY  - 2023
JO  - International journal of nanomedicine
DO  - 10.2147/ijn.s424932
UR  - https://doi.org/10.2147/ijn.s424932
ER  - 

APA

MS, A. (2023). Anticancer Analysis of CD44 Targeted Cyclosporine Loaded Thiolated Chitosan Nanoformulations for Sustained Release in Triple-Negative Breast Cancer.. International journal of nanomedicine. https://doi.org/10.2147/ijn.s424932

Source records